文献速递神经肌肉病神经免疫

肌萎缩侧索硬化中的免疫失调:机制与新兴疗法

Immune dysregulation in amyotrophic lateral sclerosis: mechanisms and emerging therapies.
PubMed 文献 · Lancet Neurol · 2019-01-01

本文综述肌萎缩侧索硬化(ALS)中神经炎症和免疫失调的证据。临床研究显示SOD1、TARDBP和C9orf72等基因突变增强神经炎症,转基因啮齿动物模型证实免疫系统参与疾病进展。即使无已知基因改变,免疫失调也导致调节性T淋巴细胞功能障碍和促炎巨噬细胞增加,新兴细胞疗法有望改善患者生活质量和延长生存。

要点

  • ALS中神经炎症表现为中枢小胶质细胞和星形胶质细胞激活、外周促炎淋巴细胞和巨噬细胞增多。
  • SOD1、TARDBP和C9orf72等ALS相关基因突变可增强神经炎症,支持免疫失调在发病中的作用。
  • 表达这些突变的转基因啮齿动物模型出现ALS样疾病伴炎症反应,证实免疫系统参与进展。

核心结论

  • 免疫失调参与ALS发病和疾病进展,新兴细胞疗法有望改善生活质量和延长生存。

研究设计与样本

  • 综述,检索范围未明确报告。

主要发现

  • 临床研究显示ALS相关基因突变(SOD1、TARDBP、C9orf72)增强神经炎症。
  • 转基因啮齿动物模型表达这些突变诱导ALS样疾病伴炎症反应,证实免疫系统参与进展。
  • 即使无已知基因改变,临床研究显示免疫失调导致调节性T淋巴细胞功能障碍和促炎巨噬细胞增加。

临床怎么用

  • 理解诱导免疫失调的生物学过程有助于识别规避或改善ALS发病机制的治疗策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Neuroinflammation is a common pathological feature of many neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS), and is characterised by activated CNS microglia and astroglia, proinflammatory peripheral lymphocytes, and macrophages. Data from clinical studies show that multiple genetic mutations linked to ALS (eg, mutations in SOD1, TARDBP, and C9orf72) enhance this neuroinflammation, which provides compelling evidence for immune dysregulation in the pathogenesis of ALS. Transgenic rodent models expressing these mutations induce an ALS-like disease with accompanying inflammatory responses, confirming the immune system's involvement in disease progression. Even in the absence of known genetic alterations, immune dysregulation has been shown to lead to dysfunctional regulatory T lymphocytes and increased proinflammatory macrophages in clinical studies. Therefore, an improved understanding of the biological processes that induce this immune dysregulation will help to identify therapeutic strategies that circumvent or ameliorate the pathogenesis of ALS. Emerging cell-based therapies hold the promise of accomplishing this goal and, therefore, improving quality of life and extending survival in patients with ALS.

来源:Lancet Neurol,查看原文。版权归原作者所有。

引用

  1. Beers DR, Appel SH. Immune dysregulation in amyotrophic lateral sclerosis: mechanisms and emerging therapies. Lancet Neurol. 2019. PMID: 30663610. doi:10.1016/S1474-4422(18)30394-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。